Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium heme polymerization is a vital detoxification process occurring within the acidic food vacuole of malaria parasites during the intraerythrocytic stage of their life cycle. As the parasite digests host hemoglobin to acquire essential amino acids, it releases free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes. To neutralize this threat, the parasite polymerizes the toxic heme into an insoluble, chemically inert crystalline pigment known as hemozoin, or malaria pigment. This pathway is a classic and highly effective therapeutic target, as its inhibition leads to the accumulation of free heme, resulting in oxidative damage and parasite death. Several major classes of antimalarial drugs, particularly quinolines like chloroquine and quinine, exert their primary effect by interfering with this crystallization process.
Inhibition of heme polymerization into hemozoin, leading to the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative stress and membrane lysis within the parasite.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium heme polymerization (PHP).